SWISS EARLY STAGE VC FIRM BUILT FOR
ENTREPRENEURS BY ENTREPRENEURS

GYANT Unveils New Solution to Manage Demand, Improve Patient Journey for Future COVID-19 Vaccine

 In Business

Great new solution from our portfolio company GYANT!

Anticipating the tsunami of inbound patient inquiries, overwhelmed call centers, appointment scheduling demands, and eligibility screening requests as the vaccine becomes available, GYANT Vaccine will virtually guide patients through the entire pre- and post-vaccination process.

“Navigating the deployment of the COVID-19 vaccine will be the single biggest challenge healthcare systems face in 2021,” said Stefan Behrens, co-founder and chief executive officer, GYANT.

News Link